Skip to content

The efficacy of rTMS on non-suicidal self-injurious behavior and its brain function changes in adolescent patients with depressive disorders

The efficacy of rTMS on non-suicidal self-injurious behavior and its brain function changes in adolescent patients with depressive disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089012
Enrollment
Unknown
Registered
2024-08-30
Start date
2024-11-06
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Control group :Sertraline hydrochloride tablets 1-2 tablets/day + Sham repeated transcranial magnetic stimulation
Experimental group:Sertraline hydrochloride tablets 1-2 tablets/day+ Repeated transcranial magnetic stimulation

Sponsors

The First Affiliated Hospital of the People's Liberation Army Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 19 Years

Inclusion criteria

Inclusion criteria: Adolescent Major Depressive Disorder with Non-Suicidal Self-Injury (NSSI) Group: 1. Aged 10–19 years; 2. Meets DSM-5 criteria for major depressive disorder; 3. Hamilton Depression Rating Scale-17 (HAMD-17) score >= 17; 4. Meets DSM-5 criteria for non-suicidal self-injury; 5. Adolescent Non-Suicidal Self-Injury Assessment Questionnaire (ANSAQ) score ? 0; 6. No antidepressant treatment of any kind (pharmacological, somatic, or psychological) within the 4 weeks prior to enrollment; 7. Right-handed; 8. After full explanation of rTMS safety, voluntarily agrees to cooperate actively with treatment; Able to comply with the study schedule, complete all procedures, and provide written informed consent together with a legal guardian. Adolescent Major Depressive Disorder with Suicidal Behavior Group: 1. Aged 10–19 years; 2. Meets DSM-5 criteria for major depressive disorder; 3. Hamilton Depression Rating Scale-17 (HAMD-17) score >= 17; 4. History of suicidal behavior; 5. Right-handed; 6. Able to complete the study procedures and provide written informed consent together with a legal guardian.

Exclusion criteria

Exclusion criteria: Adolescent Major Depressive Disorder with Non-Suicidal Self-Injury (NSSI) Group: 1. Organic brain disease; 2. Severe physical illness; 3. Other severe psychiatric disorders; 4. History of epileptic seizures; 5. Implanted devices contraindicated for rTMS (e.g., cardiac pacemaker, artificial valve, cochlear implant, or any other metal implant); current strong suicidal ideation. Adolescent Major Depressive Disorder with Suicidal Behavior Group: 1. Organic brain disease; 2. Severe physical illness; 3. Other severe psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
Adolescent Non-suicidal Self-injury Assessment ;

Secondary

MeasureTime frame
Hamilton Depression ;Hamilton Anxiety;Simplified Coping Style ;Changes in near-infrared brain functional imaging (fNIRS) compared to baseline.;Barratt Impulsiveness ;Pittsburgh Sleep Quality Index;Dimensional Anhedonia Rating ;

Countries

China

Contacts

Public ContactMin Cai

The First Affiliated Hospital of the People's Liberation Army Air Force Military Medical University

mincai8787@hotmail.com+86 153 5350 8787

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026